China remains one of the largest markets for pharmaceutical industries in the world. The China Government has been supporting research and development initiatives by various pharmaceutical companies with special attention to the biotechnology sector. The WHO has launched the Integrated Chronic Disease Prevention and Control Programme (ICP), which is one of the leading technical programmes within the Department of Chronic Diseases and Health Promotion (CHP). Such initiatives are expected to support the overall expansion of the market
Read MoreHonokiol is being researched more and recent researches prove that it promotes cellular health, supports body during oncology treatments, metabolic health, cardiovascular health, neural and cognitive health, immunity, a healthy mood, and good sleep
Read More